National Health Service (NHS) England has reached an agreement with Gilead Sciences to provide the pharmaceutical company’s chimeric antigen receptor...
Read More...
The post NHS England reaches deal with Gilead on CAR-T therapy Yescarta appeared first on Pharmaceutical Technology.
Original Article: NHS England reaches deal with Gilead on CAR-T therapy Yescarta